IP74-19: The Impact of a Generic Alternative on Medicare Part D Spending for Abiraterone

IP74-19: The Impact of a Generic Alternative on Medicare Part D Spending for Abiraterone

Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)

146A

Abstract

Speakers

Matthew Lee

Resident PhysicianMayo Clinic

Sessions

IP74: Health Services Research: Value of Care, Cost and Outcome Measures

Monday, May 18, 2026 7:00 AM to 9:00 AM

Meera Chappidi · University of California - San Francisco

Daniel Joyce · Vanderbilt University Medical Center

Jonathan Rubenstein · Chesapeake Urology Associates

Registered attendees

Ranveer Vasdev

Mayo Clinic Rochester

Log in

See all the content and easy-to-use features by logging in or registering!